aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with a mission to revolutionize cybersecurity, Morphisec provides advanced endpoint protection to prevent against the most dangerous cyberattacks, including evasive malware, in-memory exploits, zero days, and fileless attacks. The company’s core vision is to stop advanced threats without relying on detection or hunting for missed attacks. Morphisec's products focus on preemptively reducing exposure to risk and proactively preventing ransomware and other sophisticated threats at multiple stages, from early infiltration to execution.
Notable affiliated people include experienced cybersecurity professionals and investors who have recognized the critical need for innovative threat prevention. Morphisec has achieved significant milestones in the cybersecurity industry, including reducing false positives and eliminating performance impacts on protected systems. The company's impact is evident in its ability to stop attacks that bypass traditional Endpoint Detection and Response (EDR) and Next-Generation Antivirus (NGAV) solutions, thereby enhancing overall organizational security posture.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Endpoint Protection
Technology
AI
Tags
Security
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Morphisec founded?
Morphisec was founded in 2014.
Where is Morphisec’s headquarters located?
Morphisec’s headquarters is located in Boston, MA, US.
When was Morphisec’s last funding round?
Morphisec’s most recent funding round was for $31M (USD) in March 2021.
How many employees does Morphisec have?
Morphisec has 145 employees as of Feb 4, 2024.
How much has Morphisec raised to-date?
As of July 05, 2023, Morphisec has raised a total of $50M (USD) since Mar 25, 2021.
Add Comparison
Total Raised to Date
$50M
USD
Last Update Mar 25, 2021
Last Deal Details
$31M
USD
Mar 25, 2021
Series C
Total Employees Over Time
145
As of Feb 2024
Morphisec Address
11 Beacon Street
Boston,
Massachusetts
02108
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts